PNC Financial Services Group Inc. increased its position in shares of Envision Healthcare (NYSE:EVHC) by 87.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,467 shares of the company’s stock after acquiring an additional 7,659 shares during the period. PNC Financial Services Group Inc.’s holdings in Envision Healthcare were worth $633,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Maverick Capital Ltd. lifted its stake in Envision Healthcare by 30.7% during the 4th quarter. Maverick Capital Ltd. now owns 10,002,182 shares of the company’s stock worth $345,675,000 after acquiring an additional 2,349,648 shares in the last quarter. BlackRock Inc. lifted its stake in Envision Healthcare by 6.5% during the 4th quarter. BlackRock Inc. now owns 8,028,329 shares of the company’s stock worth $277,462,000 after acquiring an additional 487,314 shares in the last quarter. Guggenheim Capital LLC lifted its stake in Envision Healthcare by 140.4% during the 4th quarter. Guggenheim Capital LLC now owns 1,979,973 shares of the company’s stock worth $68,429,000 after acquiring an additional 1,156,381 shares in the last quarter. Neuberger Berman Group LLC lifted its stake in Envision Healthcare by 16.3% during the 1st quarter. Neuberger Berman Group LLC now owns 1,771,362 shares of the company’s stock worth $68,074,000 after acquiring an additional 247,802 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in Envision Healthcare by 2,034.5% during the 1st quarter. JPMorgan Chase & Co. now owns 1,683,555 shares of the company’s stock worth $64,698,000 after acquiring an additional 1,604,680 shares in the last quarter.
Get Envision Healthcare alerts:EVHC has been the topic of several research reports. Jefferies Financial Group set a $46.00 target price on Envision Healthcare and gave the stock a “buy” rating in a research note on Wednesday, April 11th. Canaccord Genuity reissued a “buy” rating and set a $46.00 target price (up previously from $32.00) on shares of Envision Healthcare in a research note on Wednesday, February 28th. Robert W. Baird set a $45.00 price target on Envision Healthcare and gave the company a “buy” rating in a research report on Monday, February 26th. Cantor Fitzgerald increased their price target on Envision Healthcare from $37.00 to $40.00 and gave the company a “neutral” rating in a research report on Wednesday, February 28th. Finally, Royal Bank of Canada reaffirmed a “buy” rating and issued a $48.00 price target on shares of Envision Healthcare in a research report on Thursday, March 1st. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating and five have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $41.59.
EVHC stock opened at $44.68 on Friday. The company has a current ratio of 2.27, a quick ratio of 2.25 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $5.42 billion, a price-to-earnings ratio of 16.82, a P/E/G ratio of 1.10 and a beta of 0.46. Envision Healthcare has a 1 year low of $23.77 and a 1 year high of $64.00.
Envision Healthcare (NYSE:EVHC) last released its quarterly earnings data on Monday, May 7th. The company reported $0.71 EPS for the quarter, beating analysts’ consensus estimates of $0.64 by $0.07. Envision Healthcare had a return on equity of 4.59% and a net margin of 1.41%. The business had revenue of $2.08 billion for the quarter, compared to the consensus estimate of $2.02 billion. During the same quarter in the prior year, the business posted $0.77 EPS. The business’s revenue for the quarter was up 10.6% on a year-over-year basis. equities analysts forecast that Envision Healthcare will post 3.41 EPS for the current fiscal year.
Envision Healthcare Company Profile
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare (NYSE:EVHC).
No comments:
Post a Comment